Dare Bioscience Inc
Research Dare Bioscience Inc (DARE) on Bullrun: market cap USD 31.46M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDARE
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 31.46M
- Financial periodFY2025
- RevenueUSD 1.03M
- Revenue growth10429.4%
- Net income-USD 13.40M
- Free cash flow-USD 10.27M
- Gross margin71.3%
Valuation Snapshot
latest market cap is USD 31.46M.
About Dare Bioscience Inc
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder;
Frequently asked questions
What is Dare Bioscience Inc's market cap?
Dare Bioscience Inc's market capitalization is USD 31.46M.
What does Dare Bioscience Inc do?
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis.